[DPHARMA] QoQ TTM Result on 30-Sep-2016 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
21-Nov-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
30-Sep-2016 [#3]
Profit Trend
QoQ- -6.31%
YoY- -1.58%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 394,690 354,464 312,940 328,308 327,738 304,911 271,040 28.50%
PBT 38,579 32,714 31,479 42,709 46,824 47,508 49,765 -15.62%
Tax -3,626 -5,098 -4,653 -9,379 -11,087 -9,864 -10,980 -52.25%
NP 34,953 27,616 26,826 33,330 35,737 37,644 38,785 -6.70%
-
NP to SH 35,484 27,890 27,115 34,022 36,314 37,659 38,785 -5.76%
-
Tax Rate 9.40% 15.58% 14.78% 21.96% 23.68% 20.76% 22.06% -
Total Cost 359,737 326,848 286,114 294,978 292,001 267,267 232,255 33.90%
-
Net Worth 463,071 463,071 454,703 451,913 510,978 457,740 270,323 43.21%
Dividend
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Div 7,085 19,142 19,142 8,084 8,084 5,682 5,682 15.86%
Div Payout % 19.97% 68.64% 70.60% 23.76% 22.26% 15.09% 14.65% -
Equity
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Net Worth 463,071 463,071 454,703 451,913 510,978 457,740 270,323 43.21%
NOSH 278,959 278,959 278,959 278,959 278,959 278,959 278,959 0.00%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin 8.86% 7.79% 8.57% 10.15% 10.90% 12.35% 14.31% -
ROE 7.66% 6.02% 5.96% 7.53% 7.11% 8.23% 14.35% -
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
RPS 141.49 127.07 112.18 117.69 102.62 109.24 162.43 -8.79%
EPS 12.72 10.00 9.72 12.20 11.37 13.49 23.24 -33.11%
DPS 2.54 6.86 6.86 2.90 2.53 2.04 3.41 -17.84%
NAPS 1.66 1.66 1.63 1.62 1.60 1.64 1.62 1.64%
Adjusted Per Share Value based on latest NOSH - 278,959
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
RPS 41.03 36.85 32.53 34.13 34.07 31.70 28.18 28.49%
EPS 3.69 2.90 2.82 3.54 3.78 3.91 4.03 -5.71%
DPS 0.74 1.99 1.99 0.84 0.84 0.59 0.59 16.31%
NAPS 0.4814 0.4814 0.4727 0.4698 0.5312 0.4759 0.281 43.22%
Price Multiplier on Financial Quarter End Date
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Date 30/06/17 31/03/17 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 -
Price 2.25 2.31 1.98 2.06 2.04 2.55 2.62 -
P/RPS 1.59 1.82 1.76 1.75 1.99 2.33 1.61 -0.83%
P/EPS 17.69 23.10 20.37 16.89 17.94 18.90 11.27 35.09%
EY 5.65 4.33 4.91 5.92 5.57 5.29 8.87 -25.98%
DY 1.13 2.97 3.47 1.41 1.24 0.80 1.30 -8.92%
P/NAPS 1.36 1.39 1.21 1.27 1.28 1.55 1.62 -11.01%
Price Multiplier on Announcement Date
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Date 25/08/17 22/05/17 24/02/17 21/11/16 22/08/16 18/05/16 23/02/16 -
Price 2.03 2.32 2.23 2.10 2.14 2.40 2.61 -
P/RPS 1.43 1.83 1.99 1.78 2.09 2.20 1.61 -7.60%
P/EPS 15.96 23.20 22.94 17.22 18.82 17.79 11.23 26.43%
EY 6.27 4.31 4.36 5.81 5.31 5.62 8.91 -20.90%
DY 1.25 2.96 3.08 1.38 1.18 0.85 1.30 -2.58%
P/NAPS 1.22 1.40 1.37 1.30 1.34 1.46 1.61 -16.89%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment